Sponsorship of oncology clinical trials in the United States according to age of eligibility.

ABSTRACT:

Background

The sponsorship mix of trials relevant to young people with cancer has not been reported. Understanding this sponsorship mix may have implications for policies and regulations related to pediatric cancer drug development.

Methods

We analyzed sponsorship of interventional trials first opened in the United States from 2007 to 2018 using the ClinicalTrials.gov registry. A total of 51 781 trials across non-oncology disciplines and 18 431 oncology trials were classified according to lower age of eligibility (≥18 years vs < 18 years). Studies were stratified according to sponsorship (industry vs non-industry). Trial characteristics were compared by sponsorship category. Trends in sponsorship were tracked over time.

Results

Within oncology trials for patients ≥ 18

SUBMITTER: Neel DV 

PROVIDER: S-EPMC7333829 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature